Managing Partner, Laidlaw & Company (UK)

Joined November 2016
28 Photos and videos
I am proud to report that AerWave Medical is beginning human trials as we seek to find relief for those suffering from lung-related ailments including COPD, asthma, and more. finance.yahoo.com/news/luciu…

119
Congrats to the Laidlaw Capital Markets team for todays 50 million dollar transaction for Biomx. Led by Deerfield, and filled in with a tremendous set of investors, a credit to the outreach effort by the team. ir.biomx.com/news-events/pre…

47
2/3 Laidlaw is responsible for taking the company public as the Sole Book Runner on Viking’s $27,600,000 IPO, priced at $8 per share.
1
41
3/3 Congratulations and thank you to the entire Viking team, their recent top-line results from the Phase 2 VENTURE trial of dual GLP-1/GIP receptor agonist VK2735 in patients with obesity has grown the company to an $8B market cap today.
64
Great event last week with our partners at @Harvard and @MassGeneralNews. We are pleased to announce $5.88 Million Award from U.S. DoD by our portfolio company Voltron Therapeutics #CancerResearch #Cancer
1
80
James Ahern retweeted
High inflation, slow growth, or a Japan-style bubble are all possible outcomes for the global economy. To protect ourselves, it is crucial to raise productivity and stimulate growth. Source @McKinsey Link mck.co/44wMdpg via @antgrasso #CEO #COO
2
62
94
11,722
“It’s clear to see that the future of AR and VR in healthcare is bright, with continued advancements in software and hardware systems driving growth. As these technologies are proven to have benefits for immersive learning and patient…” — @JamesPAhern link.medium.com/wU52oTwH9Ab
28
James Ahern retweeted
Researchers from @MassGeneralNews and colleagues are learning from the gut microbiome to identify new cancer immunotherapies, in a @nature study. doi.org/10.1038/s41586-023-0…
1
5
5
2,156
James Ahern retweeted
Today we announced the successful manufacturing of CTx-1301 doses for both of our upcoming pivotal Phase 3 trials in pediatric and adolescents with #ADHD, with the fixed-dose study scheduled to begin the week of July 24. Learn more: cingulate.com/news-releases/… $CING
2
2
6
500
James Ahern retweeted
Hope this helps! We are asked all the time about how to navigate digital integration. Tips here. Thanks to the team for getting this out for our Customers and partners! #educationforall #ArtificialIntelligence #GPT4 $AMST
Get EXCLUSIVE access to our latest FREE white paper and understand how to leverage learner data and navigate complex enterprise integrations in the age of AI. Download the white paper here: lp.amesite.io/integration-wh… #Integration #DataAnalytics #AI #ArtificialIntelligence $AMST
1
4
385
James Ahern retweeted
Research led by Christopher Hartnick, MD, and @brianskotko has proven the safety and efficacy of using hypoglossal nerve stimulation to treat obstructive sleep apnea in children with #DownSyndrome. spklr.io/6010lBCK
5
9
1,396
James Ahern retweeted
These are the ten rules of value-creating #growth 📈 Which one is the most vital? Learn more: mck.co/3qJIlTr
1
7
18
10,644
James Ahern retweeted
Silo Pharma's New #Ketamine Implant For #Fibromyalgia And Chronic Pain Is In The Making. Thank you @Benzinga for featuring our recent news. Read more here: benzinga.com/markets/cannabi… $SILO #PsychedelicResearch #Psychedelics

1
3
179
#Wearables offer huge opportunities in medicine and healthcare, they monitor vital signs, upload data to cloud in real time, and raise alerts, such as an irregular heartbeat. They literally have the potential to save lives. #healthcareinvestment intpolicydigest.org/why-now-…
19
#AI is already making an impact in healthcare training and is reshaping the methods and efficiency of learning for healthcare professionals #healthcaretraining amesite.com/blogs/revolution…

17
James Ahern retweeted
6
10
3,007